BioMedica Diagnostics Inc

We are nimble and adaptive with expertise in R&D, collaborative research, product development and manufacturing, and pilot lot development and scale-up. With products and technologies in over 70 countries, BioMedica brings innovation, quality, and affordable diagnostic solutions to an ever-growing group of international partners focused on helping to improve patient outcomes in the fields of Haemostasis and Thrombosis. Our 49,000 square foot ISO 13485:2016 MDSAP facility provides fully-automated manufacturing, dispensing, and freeze-drying for any sized contract, and for custom manufacturing of OEM, bulk and intermediary materials, as well as custom labeling. BioMedica Diagnostics is a proudly Canadian company, and a Member of the Scotia Investments Family of Companies. BioMedica is nimble and adaptive, with expertise in R&D, collaborative research, product development, and manufacturing. With core competencies in the fields of Thrombosis & Haemostasis and innovative technologies, we collaborate internationally with technology development companies and health-care stakeholders to develop and manufacture customized reagents and diagnostic solutions. Working hard to lower costs, reducing and mitigating risks to all stakeholders, we develop the tools needed for research, education, and In Vitro diagnostics.